Skip to main content

Table 3 Health resource utilization estimates based on the study of Bloudek et al. [28]

From: Economic burden of migraine in Latvia and Lithuania: direct and indirect costs

 

Chronic migraine (4.88%)

Episodic migraine (95.12%)

All migraine (100%)

Primary care physician visits (%)

54.32%

29.81%

31.01%

Mean number of visits

17.86

9.87

10.26

Neurologist/headache specialist visits (%)

30.42%

9.65%

10.67%

Mean number of visits

8.07

6.79

6.86

Nurse practitioner/physician assistant visits (%)

3.27%

1.82%

1.89%

Mean number of visits

10.89

26.19

25.45

Other specialist visits (%)

23.89%

10.17%

10.84%

Mean number of visits

14.59

11.58

11.73

Emergency room visits (%)

10.16%

5.17%

5.42%

Mean number of visits

11.53

7.16

7.37

Hospitalizations (%)

3.97%

1.91%

2.01%

Mean length of stay

19.03

9.95

10.39

Diagnostic testing (%)

20.30%

9.79%

10.30%

Mean number of diagnostic tests

13.03

10.21

10.35

Blood tests (%)

16.66%

7.09%

7.55%

Mean number of blood tests

10.11

6.32

6.51

Botulinum toxin A injections (%)

1.80%

0.77%

0.82%

Mean number of injections

6.46

7.93

7.85

Transcutaneous nerve stimulator procedures (%)

4.34%

2.07%

2.18%

Mean number of stimulator procedures

38.98

38.91

38.91

Acupuncture (%)

9.06%

4.59%

4.81%

Mean number of acupuncture

23.73

16.46

16.81

Occipital nerve block procedures (%)

3.26%

1.32%

1.42%

Mean number of nerve block procedures

8.70

11.87

11.71

  1. Percentage figures show the proportion of participants reporting one or more visits or diagnostic evaluations. The proportion of participants reporting one or more visits or diagnostic evaluations is calculated as weighted average across the five sample countries. The mean number of visits or diagnostic evaluation of Bloudek et al. [28] was translated into annual figures